<DOC>
	<DOCNO>NCT02642562</DOCNO>
	<brief_summary>This study address whether additional use Intravenous ( IV ) iron top standard care improve outlook patient heart failure iron deficiency . One group participant receive treatment iron injection group receive iron injection .</brief_summary>
	<brief_title>Intravenous Iron Treatment Patients With Heart Failure Iron Deficiency : IRONMAN</brief_title>
	<detailed_description>Chronic heart failure ( CHF ) common medical problem . Despite improvement treatment , many patient suffer limit symptom shortness breath fatigue . Hospitalisation CHF common life expectancy reduce . Many patient CHF deficiency iron ( low iron level use iron properly ) , associate poorer outcome . Some small research study suggest give patient intravenous iron improve symptom short term . It unknown , however , whether correct iron deficiency beneficial patient CHF long term whether improves life expectancy keep hospital . This study help u answer key question . This study address whether additional use Intravenous ( IV ) iron top standard care improve outlook patient heart failure iron deficiency . One group participant receive treatment iron injection group receive iron injection . The study take place 50 secondary care site ( hospital ) across UK . Participants recruited period two year follow minimum two half year ( average duration three year per participant ) . After initial visit , participant see every four month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>1 . Age ≥18 year 2 . LVEF &lt; 45 % within last 6 month use conventional imaging modality 3 . New York Heart Association ( NYHA ) class II IV 4 . Iron deficient define TSAT &lt; 20 % and/or ferritin &lt; 100 ug/L 5 . Evidence high risk HF group : Current ( intention discharge next 48 hour ) recent ( within 6 month ) hospitalisation HF , Outpatients NTproBNP &gt; 250 ng/L sinus rhythm &gt; 1,000 ng/L atrial fibrillation ( BNP &gt; 75 pg/mL 300 pg/mL , respectively ) 6 . Able willing provide inform consent 1 . Haematological criterion : ferritin &gt; 400ug/L ; haemoglobin &lt; 9.0 , &gt; 13 g/dL woman &gt; 14g/dL men ; ( B12 folate deficiency correct exclude patient ) 2 . MDRD estimate glomerular filtration rate ( eGFR ) &lt; 15ml/min/1.73m2 3 . Chronic define need IV iron therapy 4 . Likely need already receive erythropoiesis stimulate agent ( ESA ) 5 . Planned cardiac surgery revascularisation cardiac device implantation ; within 3 month primary diagnosis type 1 myocardial infarction ( exclude small troponin elevation context heart failure admission ) , cerebrovascular accident ( CVA ) , major CV surgery percutaneous coronary intervention ( PCI ) , cardiac device implantation blood transfusion ; active cardiac transplant list ; leave ventricular assist device implant 6 . Any following comorbidities : active infection ( patient suffering significant ongoing infection judge investigator recruitment postpone infection pass controlled antibiotic ) , disease life expectancy &lt; 2 year , active clinically relevant bleeding investigator opinion , know suspect gastrointestinal malignancy 7 . Pregnancy woman childbearing potential ( i.e . continue menstrual cycle ) use effective contraception see Appendix 3 . 8 . Contraindication IV iron investigator 's opinion accord current approved Summary Product Characteristics : hypersensitivity active substance , Monofer® excipients ( water injection , sodium hydroxide ( pH adjustment ) , hydrochloric acid ( pH adjustment ) ) ; know serious hypersensitivity parenteral iron product ; noniron deficiency anaemia ( e.g . haemolytic anaemia ) ; iron overload disturbance utilisation iron ( e.g . haemochromatosis , haemosiderosis ) ; decompensated liver cirrhosis hepatitis 9 . Participation another intervention study involve drug device within past 90 day ( coenrolment observational study permit )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Intravenous iron</keyword>
	<keyword>PROBE design</keyword>
</DOC>